Navigation Links
Hill-Rom Announces Agreement with Encompass Therapeutic Support Systems Adding New Surface Choice for Use with Hill-Rom Frames
Date:10/30/2008

BATESVILLE, Ind., Oct. 30 /PRNewswire-FirstCall/ -- Hill-Rom (NYSE: HRC) today announced a new agreement with Encompass Therapeutic Support Systems (Glendale, Calif.) to provide its AccuMax Quantum(TM) VPC Support Systems for use with Hill-Rom(R) bed frames.

"We are excited to move forward in our relationship with Encompass," said Mary Butler, executive director of Marketing and Strategy for Global Surfaces at Hill-Rom. "This agreement is part of our focus on developing key alliances with other leading companies in the health care area. We believe the agreement with Encompass will bring a valuable new choice to our customers as they look for the right solutions to meet the needs of their patients. Encompass offers a cost effective solution as well as proven clinical efficacy in this important product area."

Butler adds that the new agreement should enable Hill-Rom to increase options for customers who may be looking to replace only part of a bed system. Under the agreement, Hill-Rom will be the exclusive provider of this non-powered surface product for use with Hill-Rom's signature TotalCare(R) Therapy System and VersaCare(R) Bed System.

"We believe Hill-Rom's leadership expertise combined with our own innovative therapeutic surface will be appealing to customers of both companies," said David Buchicchio, vice president of Marketing & Operations, for Encompass Therapeutic Support Systems.

About Encompass Therapeutic Support Systems

Encompass Therapeutic Support Systems has for 40 years provided high quality support surfaces to the healthcare community. ETSS' customers include acute and post acute care facilities. Its products are designed to provide cost-effective solutions and improve patient outcomes across the entire healthcare spectrum. For more information, please call ETSS Customer Satisfaction Department at 800-822-8288.

About Hill-Rom

Hill-Rom is a leading worldwide manufacturer and provider of medical
'/>"/>

SOURCE Hill-Rom
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year
2. Hill-Rom Holdings, Inc. Invites You to Join its Fiscal 2008 Third Quarter Earnings Webcast
3. Hill-Rom Announces Agreement With Tri-anim to Enhance Distribution Channels for The Vest(R) System in U.S. Hospitals & Long-Term Care Facilities
4. Hill-Rom to Present at the Jefferies Healthcare Conference
5. Hill-Rom Innovative TotalCare(R) Bariatric Plus Therapy System Receives Gold Medical Device Excellence Award
6. Hill-Rom Announces Third Quarter 2008 Dividend
7. Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year
8. Hill-Rom to Present at the Citi Healthcare Conference
9. Hill-Rom to Present at the Bank of America 2008 Health Care Conference
10. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2008 Second Quarter Earnings Webcast
11. Hill-Roms NaviCare(R) WatchChild(R) Solution Provides Enhanced Information Technology Solutions for Obstetrical Care

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...oliticalEndorsements,Business,andPressJoinEffortto...ewswire/--Onceagain,theNationalBipolarFoundationan...ingtheir"Safe,tilStable"program,whichisnowbeingwid...rdisorder.Today,theNationalBipolarFoundationreceiv...ityMailfromtheLt.GovernorofLouisianaMitchLandrieu....
(Date:11/25/2009)...ave found evidence of a statistically significant ...ients whose estrogen receptor (ER)-positive tumors...t serine-118 (ER-alpha S118-P), according to a bri...he Journal of the National Cancer Institute . , ...ant to tamoxifen. Preclinical studies have shown t...
(Date:11/25/2009)...ncrease blood pressure? This simple question has ... New Stress-related gene Modulates High Blood Pre...ressure? This simple question has been the focus ...rch has for the first time established a link betw...e response to stress in mice as well as humans. Th...
(Date:11/25/2009)...ady used to fight rheumatoid arthritis, could help... , WEDNESDAY, Nov. 25 (HealthDay News) -- A drug ...rheumatoid arthritis now also shows some promise i...betes. , The drug, rituximab (Rituxan), helped ... even though the disease had destroyed some of the...
(Date:11/25/2009)...fulness could lead mothers to overlook needed care...althDay News) -- A mother,s depression can worsen ..., Their six-month study of 262 black mothers and...had more depressive symptoms had more frequent ast... depressive symptoms had less frequent asthma symp...
Breaking Medicine News(10 mins):Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:Mom's Depression May Worsen Child's Asthma 2
...he supply of blood to the part of the brain affect...lls can be seriously damaged or die, impairing loc...ttler. Within weeks of a stroke, new blood vessels...wn is what the right cellular environment is, and ...
...has indicated that blood tests which were designed...y as good //as cholesterol tests , or blood pressu...ng a veritable risk indicator. Doctors have...or CRP; homocysteine; and BNP, or B-type natriuret...
...en birth to four kids in a hospital, authorities s...hree girls and a boy in the Maharaja Agrasen Hospi... 'The condition of both the mother and the b... are weighing between 1.44 kg and 1.6 kg. La...
...rted a very interesting finding made by a group of...earchers found that obese people seem to have loa... helps to digest food well .Slim folks seem to ha...wn and the bacteria in obese people seem more hel...
...ed deaths is underestimated and underreported in t... published in Biomedical Market Newsletter//(R). ...at the number of heat-related deaths is actually 5... number of heat-related deaths during 1999-2003 th...
...suggests that lithium and other drugs that inhibit...ith caution in treating Alzheimer's disease// beca...e, neuronal function. Lithium is currently i...hese drugs are relatively easy to make and lithium...
Other Medicine News:Health News:Cellular Cues Identified for Stroke Recovery 2Health News:Intestinal Bacteria Blamed for Rotund Figures 2Health News:High Doses of Lithium-Like Drugs May Impair Neuronal Function 2
(Date:11/25/2009)...,, COLLEGEPARK,Md.,Nov.25/PRNewswire-USNewswi...havingcream-likefoamthatstopsseverebleeding,wonfir...egoryoftheGlobalSecurityChallenge2009,companyoffic...triesfromaroundtheworld,Remedium,steampitchedtheir...LondonSchoolofBusiness. ,, Remedium( www.remedi...
(Date:11/25/2009)...,, NEWYORK,Nov.25/PRNewswire/--Reportlinker.c...initscatalogue: ,, UnitedStatesDentalDevicesMa...reportlinker.com/p0158733/United-States-Dental-Dev..., UnitedStatesDentalDevicesMarketAnalysisandFor...ssentialsourceforin-depthinformationanddatarelatin...
(Date:11/25/2009)...,, WALTHAM,Mass.,Nov.25/PRNewswire/--Accordin...onmedicaltechnologymarketintelligence,thenearly$3b...toseerapidgrowthoverthenextfiveyearsdespitetherece... 2010 reportfindsthatthismarketwillremainhighlydy...ngspecializeddevicesinpreviouslyunderservedsegment...
Breaking Medicine Technology:Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Oncology Roadmap 3A Brand Spending Benchmarks and Market Forecast to 2013 61835 1Reportlinker Adds Oncology Roadmap 3A Brand Spending Benchmarks and Market Forecast to 2013 61835 2Reportlinker Adds Oncology Roadmap 3A Brand Spending Benchmarks and Market Forecast to 2013 61835 3Just like old times 3A Generating RNA molecules in water 10841 1Reportlinker Adds Toothpaste Global Market Trends 61832 1Reportlinker Adds Toothpaste Global Market Trends 61832 2Reportlinker Adds Toothpaste Global Market Trends 61832 3Reportlinker Adds Toothpaste Global Market Trends 61832 4Reportlinker Adds Toothpaste Global Market Trends 61832 5Reportlinker Adds Toothpaste Global Market Trends 61832 6Reportlinker Adds Toothpaste Global Market Trends 61832 7Reportlinker Adds Toothpaste Global Market Trends 61832 8Reportlinker Adds Toothpaste Global Market Trends 61832 9Reportlinker Adds Toothpaste Global Market Trends 61832 10
... Kiadis,Pharma announces today that the U.S. Food ...uct Reviroc(TM) Orphan Drug Designations (ODD) for...a (NHL). One ODD has been,granted for diffuse larg...ent,of follicular lymphoma. Reviroc(TM) is under d...m an autologous graft in bone marrow transplantati...
...ctivity Against Antibiotic Resistant Gram-Positive...NEW HAVEN, Conn., Dec. 8 Rib-X Pharmaceuticals, I...e company focused on the discovery, development an...reatment of antibiotic-resistant infections, today... clinical trial with the intravenous form of its n...
Other Medicine Technology:Kiadis Pharma Receives Two Orphan Drug Designations for Reviroc(TM) From the FDA 2Rib-X Pharmaceuticals Reports Positive Top-Line Results from Phase 2 Study of Delafloxacin 2Rib-X Pharmaceuticals Reports Positive Top-Line Results from Phase 2 Study of Delafloxacin 3Rib-X Pharmaceuticals Reports Positive Top-Line Results from Phase 2 Study of Delafloxacin 4
Merocel MEROWIPE Instrument Wipe
Goffman Sponge
LASIK Spear Kit
Weck-Cel Points
Medicine Products: